J Wenzel. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » HumansImmunosuppressive Agents/pharmacologyImmunosuppressive Agents/therapeutic useLupus Erythematosus, Cutaneous/drug therapyMethotrexate/pharmacologyMethotrexate/therapeutic useRetrospective StudiesSkin Physiological Phenomena/drug effectsTreatment Outcome
Substances: See more » Immunosuppressive AgentsMethotrexate
Year: 2005 PMID: 16130518 DOI: 10.1191/0961203305lu2175xx
Source DB: PubMed Journal: Lupus ISSN: 0961-2033 Impact factor: 2.911